Czech researchers are tinkerers too. If they don’t have an equipment, they build it themselves
AI-driven drug discovery, state-of-the-art laboratories, novel compounds, and nanomaterials. Czech biotechnology generates nearly CZK 100 billion annually and is beginning to gain confidence.
Biotechnology in Central Europe is growing and attracting investors
The Central European region, including the Czech Republic, is well positioned to become a major biotechnology hub in the future. Strong scientific foundations, a dynamic startup and innovation ecosystem, and current geopolitical developments all contribute to this potential. Growing investor interest in the region is reflected in venture capital and private equity investment data. At the same time, Prague is hosting BioEquity Europe 2026, Europe’s largest conference focused on investments in biotech startups. This marks the first time in the event’s 26-year history that it has been held east of Germany.
Biotech investors gather in Prague for the prestigious BioEquity Europe conference
More than a thousand international investors and leading experts in biotechnology are heading to Prague. From May 4 to 6, the city will host the prestigious international BioEquity Europe conference, which will be held in Central and Eastern Europe for the first time in its 26-year history. The event will showcase innovative projects with the potential to advance the treatment of cancer and rare diseases, connecting them with investors. In doing so, it will help accelerate their development and market entry.
Connecting Central Europe’s Emerging Biotech to Europe’s Capital Engine
The Czech Republic brought its leading life-science players to the City of Luxembourg as Great Europe, together with IOCB Tech as its General Partner, presented the Czech Life Sciences & Biotech Showcase, on December 10–12 2025. Prague.bio, the association representing major Czech life sciences stakeholders, was co-organising part of the conference to boost the sector’s global importance.
Petra Kinzlová: Czech biotech has much to offer, we want the world to see it
The Prague.bio association was founded two years ago with the aim of connecting Czech and Central European players in the field of biotechnology and strengthening their international visibility. Under the leadership of Petra Kinzlová, the association’s membership base has more than doubled, and this year in May it will bring the prestigious international conference BioEquity Europe to Prague — for the first time ever in Central and Eastern Europe.
Executive Academy for scientists launches this week: Supporting the move from lab to business
The first edition of the Executive Academy, a unique educational programme for researchers, starts this week in Prague. The new programme helps scientists in biotechnology and related fields develop managerial skills and learn how to transfer research results into practice. The official kick-off meeting brought together Academy participants, their lecturers, organisers, programme partners, and other key figures from the biotech community.
Czech startup Carebot and Bristol Myers Squibb collaborate to help detect lung cancer
More than 5,000 people die from lung cancer in the Czech Republic each year. Unfortunately, the disease is detected late in many of them, when the chance of recovery is already small. Early detection of this insidious disease gives patients a significantly higher chance of survival. This is precisely what the collaboration between Czech startup Carebot and global biopharmaceutical company Bristol Myers Squibb (BMS) focuses on – early detection.
He wanted to be an independent scientist — nobody would hire him
This Slovak conquered Oxford anyway and built a billion-dollar startup
Startup Riana Therapeutics wins at Prague.bio Conference with innovative acute leukemia therapy
Prague, September 26, 2025 – Riana Therapeutics, a startup developing a new treatment for acute myeloid leukemia, won the startup competition organized by the Prague.bio association. Second place went to HeartBeat.bio with its advanced platform for discovering new drugs for heart disease, particularly heart failure. Third place was awarded to Nanoflexion from the Technical University […]
Can Europe take the lead on biotech?
With uncertainty across the global financial markets and research community, is it Europe’s time to take the lead on biotech?